The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease: Insights From Cardiovascular Aging Science.
作者信息
AlGhatrif Majd, Cingolani Oscar, Lakatta Edward G
机构信息
Laboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, Baltimore, Maryland.
Divisions of Cardiology and Hospital Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland.
出版信息
JAMA Cardiol. 2020 Jul 1;5(7):747-748. doi: 10.1001/jamacardio.2020.1329.
Abstract
摘要
相似文献
1
The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease: Insights From Cardiovascular Aging Science.2019冠状病毒病、衰老与心血管疾病的困境：心血管衰老科学的见解
JAMA Cardiol. 2020 Jul 1;5(7):747-748. doi: 10.1001/jamacardio.2020.1329.
2
COVID-19 and the Heart.新型冠状病毒肺炎与心脏
Arq Bras Cardiol. 2020 Apr;114(4):598-600. doi: 10.36660/abc.20200209. Epub 2020 Mar 30.
3
COVID-19 in patients with cardiovascular diseases.心血管疾病患者中的新型冠状病毒肺炎
Arch Cardiovasc Dis. 2020 Apr;113(4):225-226. doi: 10.1016/j.acvd.2020.03.009. Epub 2020 Mar 31.
4
Cardiovascular disease, heart failure and COVID-19.心血管疾病、心力衰竭与2019冠状病毒病
J Renin Angiotensin Aldosterone Syst. 2020 Apr-Jun;21(2):1470320320926903. doi: 10.1177/1470320320926903.
5
Coronavirus disease 2019 and the cardiovascular system: Impacts and implications.2019冠状病毒病与心血管系统：影响与启示。
Indian Heart J. 2020 Jan-Feb;72(1):1-6. doi: 10.1016/j.ihj.2020.03.006. Epub 2020 Apr 9.
6
Letter to the Editor: Angiotensin-converting enzyme 2: an ally or a Trojan horse? Implications to SARS-CoV-2-related cardiovascular complications.致编辑的信：血管紧张素转换酶2：盟友还是特洛伊木马？对SARS-CoV-2相关心血管并发症的影响
Am J Physiol Heart Circ Physiol. 2020 May 1;318(5):H1080-H1083. doi: 10.1152/ajpheart.00215.2020. Epub 2020 Mar 30.
7
Preterm birth: Potential risk factor for greater COVID-19 severity?早产：是导致新冠病毒疾病病情更严重的潜在风险因素吗？
Respir Physiol Neurobiol. 2020 Sep;280:103484. doi: 10.1016/j.resp.2020.103484. Epub 2020 Jun 26.
8
Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?在新冠疫情期间，血管紧张素受体阻断药物是否可能有害？
J Hypertens. 2020 May;38(5):781-782. doi: 10.1097/HJH.0000000000002450.
9
Cardiovascular molecular mechanisms of disease with COVID-19.新型冠状病毒肺炎相关疾病的心血管分子机制
J Mol Cell Cardiol. 2020 Apr;141:107. doi: 10.1016/j.yjmcc.2020.04.010. Epub 2020 Apr 11.
10
Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?2019冠状病毒病（COVID-19）：血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂是否具有双相效应？
J Am Heart Assoc. 2020 Apr 7;9(7):e016509. doi: 10.1161/JAHA.120.016509. Epub 2020 Apr 1.
引用本文的文献
1
Impact of Severe COVID-19 on Accelerating Dementia Onset: Clinical and Epidemiological Insights.重症 COVID-19 对加速痴呆症发病的影响：临床与流行病学见解
medRxiv. 2025 Mar 28:2025.03.26.25324688. doi: 10.1101/2025.03.26.25324688.
2
Whole patient knowledge modeling of COVID-19 symptomatology reveals common molecular mechanisms.新冠病毒症状学的全患者知识建模揭示了常见分子机制。
Front Mol Med. 2023 Jan 4;2:1035290. doi: 10.3389/fmmed.2022.1035290. eCollection 2022.
3
Pathogenic mechanisms of cardiovascular damage in COVID-19.COVID-19 中心血管损伤的发病机制。
Mol Med. 2024 Jun 19;30(1):92. doi: 10.1186/s10020-024-00855-2.
4
Clinical characteristics and outcomes of venous thromboembolism in patients hospitalized for COVID-19: Systematic review and meta-analysis.因新冠肺炎住院患者静脉血栓栓塞症的临床特征及预后：系统评价与荟萃分析
Thromb Update. 2021;2:100037. doi: 10.1016/j.tru.2021.100037. Epub 2021 Mar 19.
5
Predictors of mortality among inpatients in COVID-19 treatment centers in the city of Butembo, North Kivu, Democratic Republic of Congo.刚果民主共和国北基伍省布滕博市新冠病毒治疗中心住院患者的死亡预测因素
PLOS Glob Public Health. 2024 Jan 24;4(1):e0002020. doi: 10.1371/journal.pgph.0002020. eCollection 2024.
6
Metabolic Syndrome Is Associated with Poor Omicron Infection Prognosis While Inactivated Vaccine Improves the Outcome of Coronavirus Disease 2019 among Chinese Inhabitants: A Retrospective Observational Study from a Chinese Municipality.代谢综合征与奥密克戎感染预后不良相关，而灭活疫苗可改善中国居民2019冠状病毒病的预后：一项来自中国某直辖市的回顾性观察研究。
Vaccines (Basel). 2023 Sep 30;11(10):1554. doi: 10.3390/vaccines11101554.
7
Epidemiological Profile of Hospitalized Patients with Cystic Fibrosis in Brazil Due to Severe Acute Respiratory Infection during the COVID-19 Pandemic and a Systematic Review of Worldwide COVID-19 in Those with Cystic Fibrosis.巴西新冠疫情期间因严重急性呼吸道感染住院的囊性纤维化患者的流行病学概况及全球囊性纤维化患者新冠感染情况的系统评价
Healthcare (Basel). 2023 Jul 4;11(13):1936. doi: 10.3390/healthcare11131936.
8
COVID-19 and the cardiovascular system: a study of pathophysiology and interpopulation variability.新型冠状病毒肺炎与心血管系统：病理生理学及人群间变异性研究
Front Microbiol. 2023 Jun 7;14:1213111. doi: 10.3389/fmicb.2023.1213111. eCollection 2023.
9
"Day 25": a temporal indicator of stabilization of mortality risk among COVID-19 patients with high viral load.“第25天”：病毒载量高的COVID-19患者死亡风险稳定的一个时间指标。
Trop Med Health. 2022 Dec 9;50(1):92. doi: 10.1186/s41182-022-00483-8.
10
Effects of Different Corticosteroid Doses in Elderly Unvaccinated Patients with Severe to Critical COVID-19.不同皮质类固醇剂量对未接种疫苗的老年重症至危重症COVID-19患者的影响
Life (Basel). 2022 Nov 18;12(11):1924. doi: 10.3390/life12111924.
本文引用的文献
1
Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19.美国心力衰竭学会/美国心脏病学会/美国心脏协会联合声明回应关于在2019冠状病毒病中使用肾素-血管紧张素-醛固酮系统拮抗剂的担忧。
J Card Fail. 2020 May;26(5):370. doi: 10.1016/j.cardfail.2020.04.013.
2
Renin-angiotensin-system, a potential pharmacological candidate, in acute respiratory distress syndrome during mechanical ventilation.肾素-血管紧张素系统，机械通气急性呼吸窘迫综合征的潜在药物靶点。
Pulm Pharmacol Ther. 2019 Oct;58:101833. doi: 10.1016/j.pupt.2019.101833. Epub 2019 Aug 1.
3
The reality of getting old.变老的现实。
Nat Rev Cardiol. 2018 Sep;15(9):499-500. doi: 10.1038/s41569-018-0068-y.
4
The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research.ACE2/血管紧张素-(1-7)/Mas 受体轴的抗炎潜力：基础与临床研究证据。
Curr Drug Targets. 2017;18(11):1301-1313. doi: 10.2174/1389450117666160727142401.
5
Age- and gender-related difference of ACE2 expression in rat lung.大鼠肺中血管紧张素转换酶2（ACE2）表达的年龄和性别相关差异。
Life Sci. 2006 Apr 4;78(19):2166-71. doi: 10.1016/j.lfs.2005.09.038. Epub 2005 Nov 21.
6
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury.血管紧张素转换酶2（ACE2）在严重急性呼吸综合征冠状病毒诱导的肺损伤中的关键作用。
Nat Med. 2005 Aug;11(8):875-9. doi: 10.1038/nm1267. Epub 2005 Jul 10.
7
Angiotensin-converting enzyme 2 protects from severe acute lung failure.血管紧张素转换酶2可预防严重急性肺衰竭。
Nature. 2005 Jul 7;436(7047):112-6. doi: 10.1038/nature03712.
8
Severe acute respiratory syndrome, Beijing, 2003.严重急性呼吸综合征，北京，2003年。
Emerg Infect Dis. 2004 Jan;10(1):25-31. doi: 10.3201/eid1001.030553.
9
Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease.动脉与心脏衰老：心血管疾病领域的主要因素：第二部分：健康状态下的衰老心脏：与心脏病的关联
Circulation. 2003 Jan 21;107(2):346-54. doi: 10.1161/01.cir.0000048893.62841.f7.
Zotero 插件